C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/18 (2006.01) A61K 38/18 (2006.01) C07K 14/475 (2006.01)
Patent
CA 2203372
SCF which includes the following C-terminal sequence: Glu Ile Cys Ser Leu Leu Ile Gly Leu Thr Ala Tyr Lys Glu Leu Ser Leu Pro Lys Arg Lys Glu Thr Cys Arg Ala Ile Gln His Pro Arg Lys Asp or a C-terminal sequence which is substantially homologous thereto and its use in medicine, particularly in ensuring the correct development of pre- implantation embryos.
Le facteur des cellules souches comprend la séquence à extrémité C-terminale suivante: Glu Ile Cys Ser Leu Leu Ile Gly Leu Thr Ala Tyr Lys Glu Leu Ser Leu Pro Lys Arg Lys Glu Thr Cys Arg Ala Ile Gln His Pro Arg Lys Asp, ou une séquence à extrémité C-terminale sensiblement homologue à celle-ci et à son utilisation en médecine afin d'assurer notamment le développement correct d'embryons pré-implantés.
Dellow Kimberley Anne
Sharkey Andrew Mark
Smith Stephen Kevin
Applied Research Systems Ars Holding N.v.
Kirby Eades Gale Baker
Merck Serono Sa
LandOfFree
Human scf, a splice variant thereof, its pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human scf, a splice variant thereof, its pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human scf, a splice variant thereof, its pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1807159